Carregant...
Patient-reported Outcomes in Metastatic Castration-sensitive Prostate Cancer in the Adjuvant Setting
We review the importance of quality of life (QOL) data from patient-reported outcome measures (PROMs) among men treated with androgen deprivation therapy (ADT) for metastatic castration-sensitive prostate cancer (mCSPC) or localized prostate cancer treated with adjuvant therapy. This information is...
Guardat en:
| Publicat a: | Eur Urol Focus |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6658671/ https://ncbi.nlm.nih.gov/pubmed/30612936 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.euf.2018.12.007 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|